Eurocine Vaccines will be in place to meet vaccine professionals from industry, academia, non-profit organizations and government to discuss challenges and successes but also present the latest news about our technology plattform Endocine™ and the latest results from the study made  with product candidate Immunose™ FLU. Date and time for the presentation will be announced later.

More information can be found at: http://www.terrapinn.com/conference/world-vaccine-congress-europe/index.stm

We welcome invitation to book meetings. PLease contat either CSO Anna-Karin Maltais or CEO Hans Arwidsson.